Zhu Hengrui, Ren Shancheng, Bitler Benjamin G, Aird Katherine M, Tu Zhigang, Skordalakes Emmanuel, Zhu Yasheng, Yan Jun, Sun Yinghao, Zhang Rugang
Gene Expression and Regulation Program, The Wistar Institute, Philadelphia, PA 19104, USA.
Department of Urology, Shanghai Changhai Hospital, Second Military Medical University, Shanghai 200433, People's Republic of China.
Cell Rep. 2015 Nov 10;13(6):1183-1193. doi: 10.1016/j.celrep.2015.09.083. Epub 2015 Oct 29.
The SPOP gene, which encodes an E3 ubiquitin ligase adaptor, is frequently mutated in a number of cancer types. However, the mechanisms by which SPOP functions as a tumor suppressor remain poorly understood. Here, we show that SPOP promotes senescence, an important tumor suppression mechanism, by targeting the SENP7 deSUMOylase for degradation. SPOP is upregulated during senescence. This correlates with ubiquitin-mediated degradation of SENP7, which promotes senescence by increasing HP1α sumoylation and the associated epigenetic gene silencing. Ectopic wild-type SPOP, but not its cancer-associated mutants, drives senescence. Conversely, SPOP knockdown overcomes senescence. These phenotypes correlate with ubiquitination and degradation of SENP7 and HP1α sumoylation, subcellular re-localization, and its associated gene silencing. Furthermore, SENP7 is expressed at higher levels in prostate tumor specimens with SPOP mutation (n = 13) compared to those with wild-type SPOP (n = 80). In summary, SPOP acts as a tumor suppressor by promoting senescence through degrading SENP7.
编码E3泛素连接酶衔接蛋白的SPOP基因在多种癌症类型中经常发生突变。然而,SPOP作为肿瘤抑制因子发挥作用的机制仍知之甚少。在此,我们表明SPOP通过靶向SENP7去SUMO化酶进行降解来促进衰老,这是一种重要的肿瘤抑制机制。SPOP在衰老过程中上调。这与泛素介导的SENP7降解相关,SENP7通过增加HP1α SUMO化和相关的表观遗传基因沉默来促进衰老。异位表达野生型SPOP而非其癌症相关突变体可驱动衰老。相反,敲低SPOP可克服衰老。这些表型与SENP7的泛素化和降解、HP1α SUMO化、亚细胞重新定位及其相关基因沉默相关。此外,与具有野生型SPOP的前列腺肿瘤标本(n = 80)相比,具有SPOP突变的前列腺肿瘤标本(n = 13)中SENP7的表达水平更高。总之,SPOP通过降解SENP7促进衰老,从而发挥肿瘤抑制作用。